|
Status |
Public on Dec 01, 2010 |
Title |
BreastCancer-019 (miRNA) |
Sample type |
RNA |
|
|
Source name |
Breast Primary Tumor
|
Organism |
Homo sapiens |
Characteristics |
tissue: breast disease state: breast primary tumor breast cancer subtype: Lum A tp53 mutation status: WT death status: Dead of BC disease free survival time (months): 52.5657894736842 estrogen receptor status: Positive her2 (fish) status: Negative
|
Treatment protocol |
fresh frozen in liquid nitrogen
|
Extracted molecule |
total RNA |
Extraction protocol |
TRIzol, following manufactors protocol
|
Label |
Cy3
|
Label protocol |
Agilent miRNA Labeling Reagent and Hybridization Kit, Protocol v.1.5
|
|
|
Hybridization protocol |
Agilent miRNA Labeling Reagent and Hybridization Kit, Protocol v.1.5
|
Scan protocol |
Scanning on Agilent scanner G2565A.
|
Description |
BC-M-019 This breast tumor sample has previously been assayed in Series GSE3985.
|
Data processing |
Feature Extraction (FE) v9.5.3.1 was used to extract signals. The Sample VALUEs represent log2 75th percentile-normalized signal intensities.
|
|
|
Submission date |
Dec 17, 2009 |
Last update date |
Apr 17, 2010 |
Contact name |
Hilde Johnsen |
E-mail(s) |
[email protected]
|
Phone |
004722934421
|
Fax |
004722934440
|
Organization name |
Norwegian Radium Hospital
|
Department |
Genetics
|
Street address |
Montebello
|
City |
Oslo |
ZIP/Postal code |
0310 |
Country |
Norway |
|
|
Platform ID |
GPL8227 |
Series (2) |
GSE19536 |
Molecular Characterization of Breast Cancer Subtypes Derived from Joint Analysis of High Throughput miRNA and mRNA Data |
GSE19783 |
Molecular Characterization of Breast Cancer Subtypes from Joint Analysis of High Throughput miRNA and mRNA Data (II) |
|